MX2025014366A - Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos - Google Patents
Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicosInfo
- Publication number
- MX2025014366A MX2025014366A MX2025014366A MX2025014366A MX2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A
- Authority
- MX
- Mexico
- Prior art keywords
- psychiatric
- disorders
- treatment
- psychoactive drugs
- neurological diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363471412P | 2023-06-06 | 2023-06-06 | |
| US202363602904P | 2023-11-27 | 2023-11-27 | |
| US202363605729P | 2023-12-04 | 2023-12-04 | |
| US202363607702P | 2023-12-08 | 2023-12-08 | |
| US202463553788P | 2024-02-15 | 2024-02-15 | |
| US202463649653P | 2024-05-20 | 2024-05-20 | |
| PCT/US2024/032615 WO2024254190A2 (en) | 2023-06-06 | 2024-06-05 | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2025014366A true MX2025014366A (es) | 2026-02-03 |
Family
ID=98099691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2025014366A MX2025014366A (es) | 2023-06-06 | 2024-06-05 | Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4724433A2 (de) |
| KR (1) | KR20260053276A (de) |
| AU (1) | AU2024284688A1 (de) |
| IL (1) | IL324918A (de) |
| MX (1) | MX2025014366A (de) |
-
2024
- 2024-06-05 MX MX2025014366A patent/MX2025014366A/es unknown
- 2024-06-05 KR KR1020267000265A patent/KR20260053276A/ko active Pending
- 2024-06-05 IL IL324918A patent/IL324918A/en unknown
- 2024-06-05 AU AU2024284688A patent/AU2024284688A1/en active Pending
- 2024-06-05 EP EP24819953.1A patent/EP4724433A2/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4724433A2 (de) | 2026-04-15 |
| AU2024284688A1 (en) | 2025-12-11 |
| IL324918A (en) | 2026-01-01 |
| KR20260053276A (ko) | 2026-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2026002446A (es) | Compuestos macrociclicos, metodo de preparacion de estos y uso de estos | |
| ECSP21004787A (es) | Inhibidores de inflamasoma nlrp3 | |
| AR127050A1 (es) | Compuestos espirocíclicos | |
| ECSP034602A (es) | Derivados sustituidos 2-fenilaminoimidazolina fenil cetona como antagonistas ip | |
| AR123685A1 (es) | Antagonistas del mrgx2 | |
| MX2024009161A (es) | Compuestos de pirrolidina. | |
| CY1124708T1 (el) | Φαρμακολογικως δραστικα αλικυκλικα υποκατεστημενα παραγωγα πυραζολο[1,5-a] πυριμιδινης | |
| CL2020001020A1 (es) | Derivados de bencimidazol y sus usos. | |
| CO2022006087A2 (es) | Métodos para el tratamiento de la trombocitopenia inmunitaria mediante la administración de (r)-2-[3-[4-amino-3-(2-fluoro-4-fenoxi-fenil)pirazolo[3,4-d]pirimidin-1-il]piperidino-1-carbonil]-4-metil-4-[4-(oxetan-3-il)piperazin-1-il]pent-2-enonitrilo | |
| CR20240536A (es) | Compuestos amido heteroaromáticos útiles en el tratamiento de enfermedades hepáticas | |
| CO2025015728A2 (es) | Conjugados que comprenden enlazadores escindibles | |
| CO2023001367A2 (es) | Derivados de pirazolo[1,5-a]pirimidina sustituidos con heterocíclicos farmacológicamente activos | |
| AR131735A1 (es) | Agentes terapéuticos | |
| MX2025013370A (es) | Inhibidores de moléculas pequeñas de glutaminasa | |
| MX2024012095A (es) | Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos | |
| MX2021008213A (es) | Derivados de (2,5-dioxopirrolidina-1-il)(fenil)-acetamida y su uso en el tratamiento de enfermedades neurologicas. | |
| CO2026003028A2 (es) | Conjugados que comprenden enlazadores escindibles | |
| ECSP19084722A (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
| AR035008A1 (es) | Compuestos pirimidin-2, 4, 6-trionas, su uso para la fabricacion de un medicamento y composicion farmaceutica que los comprende | |
| CO2024014215A2 (es) | Formulaciones de inhibidor de tyk2 y métodos para elaborarlas | |
| AR038046A1 (es) | Derivados de acidos 3-fenil-2-arilalquiltiopropionicos moduladores de ppar alfa | |
| WO2024254190A3 (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| CL2024003257A1 (es) | Compuestos heteroaromáticos bicíclicos condensados y su uso en el tratamiento del cáncer | |
| AR127170A1 (es) | Antagonistas del receptor de la hormona paratiroidea (pth) y sus usos | |
| MX2024009770A (es) | Procesos para la preparacion de derivados de 1,2,3,5,6,7-hexahidro -s-indaceno. |